Structures by: Martins F. T.
Total: 126
C14H13N3O3
C14H13N3O3
The Journal of organic chemistry (2018) 83, 7 3516-3528
a=9.3777(9)Å b=10.5101(12)Å c=13.0183(13)Å
α=90° β=90° γ=90°
C16H18BrNO2
C16H18BrNO2
The Journal of organic chemistry (2018) 83, 4 1761-1771
a=7.991(3)Å b=8.632(3)Å c=11.023(4)Å
α=109.502(16)° β=100.029(16)° γ=93.386(16)°
C8H13CdN3O5
C8H13CdN3O5
Journal of the American Chemical Society (2019) 141, 8 3400-3403
a=7.5660(4)Å b=21.7993(11)Å c=8.4539(4)Å
α=90° β=117.515(2)° γ=90°
Diethylcarbamazine citrate
C10H22N3O,C6H7O7
Crystal Growth & Design (2010) 10, 7 3094
a=13.8050(3)Å b=10.2581(2)Å c=13.9890(3)Å
α=90.00° β=93.689(2)° γ=90.00°
Diethylcarbamazine citrate
C6H7O7,C10H22N3O
Crystal Growth & Design (2010) 10, 7 3094
a=13.915(2)Å b=10.096(2)Å c=14.089(3)Å
α=90.0000° β=103.56(1)° γ=90.0000°
Diethylcarbamazine citrate
C10H22N3O,C6H7O7
Crystal Growth & Design (2010) 10, 7 3094
a=27.4386(7)Å b=10.1644(2)Å c=14.0536(3)Å
α=90.00° β=95.033(1)° γ=90.00°
Diethylcarbamazine citrate
C10H22N3O,C6H7O7
Crystal Growth & Design (2010) 10, 7 3094
a=13.656(5)Å b=10.259(5)Å c=13.902(6)Å
α=90.140(3)° β=95.389(3)° γ=92.677(3)°
Lamivudine double strand
C75H114Cl2N24O37S8
Crystal Growth & Design (2010) 10, 2 676
a=14.22190(20)Å b=25.60790(29)Å c=15.17540(20)Å
α=90.00° β=117.4652(5)° γ=90.00°
Didanosine
C10H12N4O3,0.125H2O
Crystal Growth & Design (2010) 10, 4 1885
a=7.277(1)Å b=10.052(2)Å c=14.476(3)Å
α=90.000° β=93.71(1)° γ=90.000°
Hexagram-Type Topology Lamivudine Duplex
3(C8H11N3O3S),2(H2O)
Crystal Growth & Design (2012) 12, 10 5138
a=14.550(1)Å b=14.550(1)Å c=29.538(3)Å
α=90.00° β=90.00° γ=120.00°
Lamivudine hemihydrochloride hemihydrate
C8H12N3O3S,C8H11N3O3S,H2O,Cl
Crystal Growth & Design (2012) 12, 10 5138
a=6.972(5)Å b=12.167(7)Å c=13.867(8)Å
α=100.52(3)° β=93.15(4)° γ=91.43(4)°
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1- benzoxazin-2-one 1,2-bis(4-pyridyl)ethene cocrystal
C40H28Cl2F6N4O4
Crystal Growth & Design (2013) 13, 4 1558
a=5.1586(6)Å b=8.9072(9)Å c=20.768(2)Å
α=86.317(7)° β=86.355(7)° γ=73.313(7)°
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1- benzoxazin-2-one 1,2-bis(4-pyridyl)ethane cocrystal
C40H30Cl2F6N4O4
Crystal Growth & Design (2013) 13, 4 1558
a=5.3101(4)Å b=8.6465(5)Å c=20.7050(14)Å
α=84.956(4)° β=85.946(4)° γ=74.581(4)°
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1- benzoxazin-2-one
C14H9ClF3NO2
Crystal Growth & Design (2013) 13, 4 1558
a=16.656(7)Å b=5.312(2)Å c=17.227(7)Å
α=90° β=113.59(3)° γ=90°
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-(1H)-pyrimidin-2-one maleate
C8H12N3O3S,C4H3O4
Crystal Growth & Design (2009) 9, 12 5283
a=5.4584(3)Å b=12.8761(8)Å c=21.8161(13)Å
α=90.00° β=90.00° γ=90.00°
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-(1H)-pyrimidin-2-one maleate
C8H12N3O3S,C4H3O4
Crystal Growth & Design (2009) 9, 12 5283
a=5.4130(1)Å b=12.7870(4)Å c=21.6501(7)Å
α=90.00° β=90.00° γ=90.00°
Chlortalidone Form I
C14H11ClN2O4S
Crystal Growth & Design (2009) 9, 7 3235
a=6.2270(2)Å b=8.3870(3)Å c=14.3640(4)Å
α=92.141(2)° β=101.050(2)° γ=107.024(2)°
Chlortalidone Form III
C14H11ClN2O4S
Crystal Growth & Design (2009) 9, 7 3235
a=7.9957(2)Å b=8.1467(2)Å c=11.4761(3)Å
α=80.448(2)° β=79.277(2)° γ=86.106(2)°
C78H74N2Na4O26
C78H74N2Na4O26
CrystEngComm (2016) 18, 37 6987
a=21.0771(7)Å b=21.0771(7)Å c=16.6303(5)Å
α=90° β=90° γ=90°
Lamivudine_Hydrofluoride
C8H12N3O3S,F2H
CrystEngComm (2015) 17, 28 5187
a=5.35980(10)Å b=12.0206(4)Å c=8.6306(3)Å
α=90° β=104.5500(10)° γ=90°
Lamivudine_Hydrobromide
C8H12Br1N3O3S1
CrystEngComm (2015) 17, 28 5187
a=5.689(5)Å b=12.288(5)Å c=8.419(5)Å
α=90° β=103.897(5)° γ=90°
Zalcitabine hydrochloride
C9H14N3O3,Cl
CrystEngComm (2014) 16, 30 7013
a=5.4672(20)Å b=11.9780(29)Å c=8.5397(20)Å
α=90.00° β=105.3269(18)° γ=90.00°
Doxycycline chloride salt dihydrate
C22H25N2O81,2(H2O1),Cl11)
Crystal Growth & Design (2014) 14, 8 3711
a=11.0979(1)Å b=12.7557(1)Å c=16.8829(2)Å
α=90° β=90° γ=90°
C26H38.4Cu2KN8NaO16.2
C26H38.4Cu2KN8NaO16.2
Inorganic chemistry (2016) 55, 5 2390-2401
a=22.521(18)Å b=13.220(18)Å c=24.87(3)Å
α=90.00° β=90.00° γ=90.00°
C34H62Cu2N10O16
C34H62Cu2N10O16
Inorganic chemistry (2016) 55, 5 2390-2401
a=22.407(3)Å b=15.961(2)Å c=16.0589(18)Å
α=90.00° β=116.624(2)° γ=90.00°
C18H36Cl2Cu2N6Na6O27
C18H36Cl2Cu2N6Na6O27
Inorganic chemistry (2016) 55, 5 2390-2401
a=13.0966(8)Å b=21.1127(13)Å c=14.9035(8)Å
α=90.00° β=90.00° γ=90.00°